Product
Chirorab
1 clinical trial
2 indications
Indication
RabiesIndication
PreventionClinical trial
A Phase III, Randomized, Comparator-Controlled, Double-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Lot to Lot Consistency of Three Lots of a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried in Healthy Adults Using a Post-Exposure Prophylaxis ScheduleStatus: Active (not recruiting), Estimated PCD: 2024-03-22